ASP1128 (MA-0217)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASP1128 (MA-0217), covering 2022-10-04 to 2022-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery [Phase 2]